In a study published online July 9 in Blood Cancer Discovery, real-world outcomes are described for teclistamab, a ...

Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...

Surge in dengue and chikungunya cases peaks as monsoon season arrives. Protect yourself and especially children and pregnant women as they are more susceptible to mosquito-borne illness.

ImmunityBio’s ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.